Yvette Crawley

527 total citations
8 papers, 396 citations indexed

About

Yvette Crawley is a scholar working on Physiology, Molecular Biology and Oncology. According to data from OpenAlex, Yvette Crawley has authored 8 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Yvette Crawley's work include Asthma and respiratory diseases (6 papers), Neuroscience of respiration and sleep (1 paper) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper). Yvette Crawley is often cited by papers focused on Asthma and respiratory diseases (6 papers), Neuroscience of respiration and sleep (1 paper) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper). Yvette Crawley collaborates with scholars based in United States. Yvette Crawley's co-authors include Robert W. Egan, William Kreutner, Richard W. Chapman, Michael Minnicozzi, T T Kung, Ted T. Kung, Charles G. Garlisi, Dawn Stelts, H. Jones and Xiomara Fernandez and has published in prestigious journals such as Biochemical Journal, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

Yvette Crawley

8 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yvette Crawley United States	8	202	123	112	95	44	8	396
Megan Larmore United States	9	92 0.5×	102 0.8×	45 0.4×	80 0.8×	24 0.5×	14	315
Jay A. Nadel United States	9	167 0.8×	31 0.3×	129 1.2×	110 1.2×	23 0.5×	11	387
Joris J. De Bie Netherlands	7	205 1.0×	168 1.4×	79 0.7×	64 0.7×	84 1.9×	7	376
Karine Brochu‐Gaudreau Canada	9	99 0.5×	44 0.4×	33 0.3×	171 1.8×	16 0.4×	15	473
Jean DeB. Butler United States	8	109 0.5×	43 0.3×	139 1.2×	140 1.5×	4 0.1×	10	426
Bertha A. Marroquin United States	10	115 0.6×	102 0.8×	143 1.3×	113 1.2×	28 0.6×	10	354
Andrea Fuhrer Switzerland	6	51 0.3×	96 0.8×	60 0.5×	124 1.3×	9 0.2×	11	433
Anick Langlois Canada	11	173 0.9×	161 1.3×	72 0.6×	98 1.0×	51 1.2×	15	382
Patricia Ramos‐Ramírez Sweden	12	147 0.7×	167 1.4×	68 0.6×	73 0.8×	38 0.9×	23	384
Kentaro Machida Japan	12	174 0.9×	123 1.0×	131 1.2×	164 1.7×	33 0.8×	34	471

Countries citing papers authored by Yvette Crawley

Since Specialization

Citations

This map shows the geographic impact of Yvette Crawley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvette Crawley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvette Crawley more than expected).

Fields of papers citing papers by Yvette Crawley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvette Crawley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvette Crawley. The network helps show where Yvette Crawley may publish in the future.

Co-authorship network of co-authors of Yvette Crawley

This figure shows the co-authorship network connecting the top 25 collaborators of Yvette Crawley. A scholar is included among the top collaborators of Yvette Crawley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvette Crawley. Yvette Crawley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Fernandez, Xiomara, Garfield G. Mingo, Yanlin Jia, et al.. (2013). Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models. European Journal of Pharmacology. 718(1-3). 290–298. 32 indexed citations

Kung, T T, Yvette Crawley, H. Jones, et al.. (2004). Tachykinin NK3-receptor deficiency does not inhibit pulmonary eosinophilia in allergic mice. Pharmacological Research. 50(6). 611–615. 38 indexed citations

Wang, Peng, Ji Zhang, Hong Bian, et al.. (2004). Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor. Biochemical Journal. 380(2). 425–433. 47 indexed citations

Chapman, Richard W., Yvette Crawley, Robert W. Egan, et al.. (2003). Inhibition of experimental acute pulmonary inflammation by pirfenidone. Pulmonary Pharmacology & Therapeutics. 16(4). 207–214. 44 indexed citations

Kung, Ted T., Bin Luo, Yvette Crawley, et al.. (2001). Effect of Anti-mIL-9 Antibody on the Development of Pulmonary Inflammation and Airway Hyperresponsiveness in Allergic Mice. American Journal of Respiratory Cell and Molecular Biology. 25(5). 600–605. 64 indexed citations

Kung, T T, Yvette Crawley, Bin Luo, et al.. (2000). Inhibition of pulmonary eosinophilia and airway hyperresponsiveness in allergic mice by rolipram: involvement of endogenously released corticosterone and catecholamines. British Journal of Pharmacology. 130(2). 457–463. 30 indexed citations

Garlisi, Charles G., Ted T. Kung, Peng Wang, et al.. (1999). Effects of Chronic Anti-Interleukin-5 Monoclonal Antibody Treatment in a Murine Model of Pulmonary Inflammation. American Journal of Respiratory Cell and Molecular Biology. 20(2). 248–255. 52 indexed citations

Feder, Lisa S, Dawn Stelts, Richard W. Chapman, et al.. (1997). Role of Nitric Oxide on Eosinophilic Lung Inflammation in Allergic Mice. American Journal of Respiratory Cell and Molecular Biology. 17(4). 436–442. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact